Pape, Judith
Magdeldin, Tarig
Stamati, Katerina
Nyga, Agata
Loizidou, Marilena
Emberton, Mark
Cheema, Umber
Funding for this research was provided by:
RCUK | Engineering and Physical Sciences Research Council
DH | National Institute for Health Research
Article History
Received: 18 November 2019
Revised: 11 May 2020
Accepted: 17 June 2020
First Online: 9 July 2020
Ethics approval and consent to participate
: Primary human colorectal cancer-associated fibroblasts were obtained in accordance with the Declaration of Helsinki. Samples were isolated from tumour tissues acquired from surgeries at the Royal Free Hospital. Patients provided informed consent for tissue donation for research under ethics reference 11/WA/0077 obtained through the North Wales Research Ethics Committee (Central and East) through TAPb biobank.
: Not applicable.
: The data that support the findings of this study are available from the corresponding author (U.C.) on reasonable request.
: The authors declare no competing interests.
: Judith Pape receives a stipend and EU fee funding from the EPSRC as part of the doctoral training programme (DTP). Mark Emberton receives research support from the United Kingdom’s National Institute of Health Research (NIHR) UCLH/UCL Biomedical Research Centre and became an NIHR Senior Investigator in 2015. This work was funded by the NIHR Invention for Innovation (i4i) programme. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.